• Parkinson’s Research

  VY-AADC for Parkinson’s Granted Advanced Therapy Designation

  Posted by Forum Moderator on July 2, 2018 at 8:12 am

  The U.S. Food and Drug Administration has granted VY-AADC, a gene therapy candidate, a regenerative medicine advanced therapy (RMAT) designation for Parkinson’s treatment.

  Click here to read more: FDA Grants Regenerative Medicine Advanced Therapy Designation to VY-AADC for Parkinson’s

  Are you familiar with VY-AADC? What do you think of this news?

  replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply